B-ALL Follow-Up Flow Panel
Also known as: B-Cell Acute Lymphoblastic Leukemia Flow Follow-Up Panel
Use
The B-ALL Follow-Up Flow Panel is used for assessing patients with B-acute lymphoblastic leukemia (B-ALL) during treatment follow-up. The panel helps in determining leukemic cell populations and guides ongoing clinical management by providing critical immunophenotypic details. Prior immunophenotyping at NeoGenomics is strongly recommended for proper comparative analysis.
Special Instructions
Available only as tech-only. Requires prior immunophenotyping with Standard or Extended Flow Panel at NeoGenomics. Clients must provide previous flow cytometry reports, pathology reports, and/or clinical history notes.
Limitations
This test is available only as tech-only and requires specific prior testing at NeoGenomics. The use of lithium heparin or ACD tubes may compromise sample integrity, and specimens must be transported as per stated storage and transportation guidelines to ensure cell viability.
New York Approved
Methodology
Cell-based / Cytometry (Flow Cytometry)
Biomarkers
Result Turnaround Time
24 hours
Related Documents
For more information, please review the documents below
Specimen
Bone Marrow
Volume
1-2 mL
Minimum Volume
Not provided
Container
EDTA or Sodium heparin
Collection Instructions
Sodium heparin is acceptable. Lithium heparin or ACD not acceptable. Provide recent CBC report.
Storage Instructions
Refrigerate. Do not freeze. Use cold pack for transport.